Cargando…
Identifying the role of apolipoprotein A-I in prostate cancer
Although localized prostate cancer (PCa) can be cured by prostatectomy and radiotherapy, the development of effective therapeutic approaches for advanced prostate cancer, including castration-resistant PCa (CRPC) and neuroendocrine PCa (NEPC), is lagging far behind. Identifying a novel prognostic an...
Autores principales: | Wang, Jing, Xu, Ling-Fan, Liu, Cheng, Huang, Tao, Liang, Chao-Zhao, Fan, Yi-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269822/ https://www.ncbi.nlm.nih.gov/pubmed/33586698 http://dx.doi.org/10.4103/aja.aja_92_20 |
Ejemplares similares
-
The role of glutamine metabolism in castration-resistant prostate cancer
por: Zhao, Bing, et al.
Publicado: (2023) -
Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast Cancer
por: Sun, Yadong, et al.
Publicado: (2016) -
Prognostic value of the serum apolipoprotein B to apolipoprotein A-I ratio in metastatic colorectal cancer patients
por: Yang, Dong-Dong, et al.
Publicado: (2020) -
Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro
por: Su, Wei‐peng, et al.
Publicado: (2018) -
Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer
por: Wang, Min, et al.
Publicado: (2019)